Patrick I. Borgen, MD, Discusses Treatment Advances to Watch for in HER2-Positive Breast Cancer
December 19, 2019
The breast cancer expert discussed 2 advances in HER2-positive breast cancer treatment that healthcare providers should look for.
Patrick I. Borgen, MD
Patrick I. Borgen, MD, Discusses Upcoming Breast Cancer Conferences
December 3, 2019
The breast cancer expert discussed the importance of attending breast cancer meetings like the San Antonio Breast Cancer Symposium and the Miami Breast Cancer Conference.
Managing Ductal Carcinoma In Situ in the Era of Genomic Profiling
March 20, 2018
At the 2018 Miami Breast Cancer Conference, Dr. Patrick Borgen presented information related to gene expression profiling as a tool for managing DCIS.
